Publications by authors named "Angie Coste"

Claim this Profile
A
A Novel Prescription Digital Therapeutic Option for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease.
Naim Alkhouri, Katherine Edwards, Mark Berman, Heather Finn, Rafael Escandon, Angie Coste

Gastro Hep Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial.
Eric J Lawitz, Diane E Shevell, Giridhar S Tirucherai, Shuyan Du, Warner Chen, Angie Coste

Hepatology· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ombitasvir/paritaprevir/ritonavir + dasabuvir +/- ribavirin in real world hepatitis C patients.
Nicole Loo, Eric Lawitz, Naim Alkhouri, Jennifer Wells, Carmen Landaverde, Angie Coste

World J Gastroenterol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis.
Eric J Lawitz, Angie Coste, Fred Poordad, Naim Alkhouri, Nicole Loo

Clin Gastroenterol Hepatol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis